Delivery Order SPE2DB20D3103-SPE2DB24FQ1W8
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,027.93, is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3FH9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,037.22 firm fixed-price delivery order is for the pharmaceutical product XYLOCAINE-MPF 2% VIAL 5ML, with an ultimate completion date of October 27, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $3,056.94 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication, with a completion date of June 13, 2024. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,491.66 firm fixed-price delivery order contract is for the supply of XYLOCAINE 1%-EPI 1:100,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of March 7, 2024 and was awarded on March 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,179.40, is for the delivery of pharmaceutical products, specifically XYLOCAINE-MPF 1%-EPI 1:200,000 30ML, to support various government agencies and healthcare programs. The contract is a firm fixed-price Delivery Order, with a period of performance running through September 2024. Amerisourcebergen, a major supplier of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply XYLOCAINE-MPF 2% 100 MG/5 ML 5ML pharmaceuticals. The $1,742.00 delivery order has a completion date of January 11, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities to support military treatment programs. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,727.07, is for the delivery of XYLOCAINE 2%-EPI 1:200,000 20ML, a local anesthetic medication, with a completion date of January 5, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $13,084.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of XYLOCAINE 2% 5ML 25S, a pharmaceutical product, with a completion date of June 13, 2023. The contract is a firm fixed-price arrangement without any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of Xylocaine-MPF 2% Vial 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,367.62 and an ultimate completion date of November 7, 2022. The award was made on November 4, 2022. Amerisourcebergen Drug Corp is a subsidiary of...